Bacterin Announces Selection of Executive Search Firm

  Bacterin Announces Selection of Executive Search Firm

Business Wire

BELGRADE, Mont. -- April 26, 2013

Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the
development of revolutionary bone graft material and coatings for medical
applications, today announced the selection of O’Hara Associates, Inc. of
Deerfield, Illinois to assist in the recruitment of a Chief Executive Officer.

The recommendation to retain the firm was made by the Board’s Nominations and
Corporate Governance Committee. “Our selection of O’Hara Associates was based
on its expertise and history of locating senior executives for companies in
the medical technology sector,” said Jon Wickwire, Director and Chairman of
Corporate Governance and Nominating Committee for Bacterin International.
“While we have already received a number of candidates, our goal will be to
move through the selection process prudently and expeditiously so that we can
focus on growing the business and developing the markets we serve.”

The Search Committee engaged in an extensive process that included the review
of three proposals, and numerous interviews with search consultants from
around the country.

O’Hara Associates is headed by Dan O’Hara who brings more than 20 years of
experience in executing retained search projects at the CEO level for various
client organizations within the medical device, pharmaceutical, and Healthcare
IT sectors.

About Bacterin International Holdings

Bacterin International Holdings, Inc. (NYSE MKT: BONE) develops, manufactures
and markets biologics products to domestic and international markets.
Bacterin's proprietary methods optimize the growth factors in human allografts
to create the ideal stem cell scaffold to promote bone, subchondral repair and
dermal growth. These products are used in a variety of applications including
enhancing fusion in spine surgery, relief of back pain, promotion of bone
growth in foot and ankle surgery, promotion of cranial healing following
neurosurgery and subchondral repair in knee and other joint surgeries.

Bacterin's Medical Device division develops, employs, and licenses coatings
for various medical device applications. For further information, please visit

About O’Hara Associates, Inc.

Headquartered in Deerfield, Illinois, our experience spans more than 20 years
in retained executive search consulting. Our client base includes large and
mid-cap multinational, public and private enterprises, as well as a range of
premier private equity and venture financed companies. For more information
about our firm please visit us at:

Important Cautions Regarding Forward-looking Statements

This news release contains certain disclosures that may be deemed
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995 that are subject to significant risks and
uncertainties. Forward-looking statements include statements that are
predictive in nature, that depend upon or refer to future events or
conditions, or that include words such as "continue," "efforts," "expects,"
"anticipates," "intends," "plans," "believes," "estimates," "projects,"
"forecasts," "strategy," "will," "goal," "target," "prospects," "potential,"
"optimistic," "confident," "likely," "probable" or similar expressions or the
negative thereof. Statements of historical fact also may be deemed to be
forward-looking statements. We caution that these statements by their nature
involve risks and uncertainties, and actual results may differ materially
depending on a variety of important factors, including, among others: the
Company's ability to launch beta and full product releases; the Company's
ability to meet its obligations under existing and anticipated contractual
obligations; the Company's ability to develop, market, sell and distribute
desirable applications, products and services and to protect its intellectual
property; the ability of the Company's sales force to achieve expected
results; the ability of the Company's customers to pay and the timeliness of
such payments, particularly during recessionary periods; the Company's ability
to obtain financing as and when needed; changes in consumer demands and
preferences; the Company's ability to attract and retain management and
employees with appropriate skills and expertise; the impact of changes in
market, legal and regulatory conditions and in the applicable business
environment, including actions of competitors; and other factors. Additional
risk factors are listed in the Company's Annual Report on Form 10-K under the
heading "Risk Factors." The Company undertakes no obligation to release
publicly any revisions to any forward-looking statements to reflect events or
circumstances after the date hereof or to reflect the occurrence of
unanticipated events, except as required by law.


For Bacterin
Rich Cockrell, 877-889-1972
Press spacebar to pause and continue. Press esc to stop.